...
首页> 外文期刊>Neuropharmacology >The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition.
【24h】

The novel NTPDase inhibitor sodium polyoxotungstate (POM-1) inhibits ATP breakdown but also blocks central synaptic transmission, an action independent of NTPDase inhibition.

机译:新型NTPDase抑制剂聚氧钨酸钠(POM-1)抑制ATP分解,但也阻断中枢突触传递,其作用独立于NTPDase抑制。

获取原文
获取原文并翻译 | 示例

摘要

Understanding the mechanisms and properties of purinergic signalling would be greatly assisted by the discovery of subtype selective and potent inhibitors of the NTPDase enzymes, which metabolise nucleotides such as ATP and ADP in the extracellular space. Currently ARL 67156 is the best available NTPDase inhibitor, but its relatively poor efficacy means that negative results are difficult to interpret. POM-1 (sodium polyoxotungstate) is a novel NTPDase inhibitor, which has shown promising results with the inhibition of recombinant NTPDases 1, 2 and 3. We have tested the effectiveness and physiological effects of POM-1 with cerebellar and hippocampal slices. Using the malachite green phosphate assay, HPLC and biosensor measurements we have found that POM-1 is more effective at blocking ATP breakdown in cerebellar slices than ARL 67156. The site of inhibition is at the first step of the breakdown cascade (conversion of ATP to ADP) and the effects of POM-1 appear readily reversible. However, POM-1 has multiple effects on synaptic transmission. At the cerebellar parallel fibre-Purkinje cell (PF) synapse POM-1 produced a long lasting inhibition of transmission, which was preceded in a minority of synapses by a transient increase in PF excitatory postsynaptic potential (EPSP) amplitude (approximately 20%). This increase in PF EPSP amplitude appears to result from a reduction in the tonic activation of presynaptic A1 receptors, consistent with POM-1 preventing the breakdown of ATP to adenosine. The reduction in PF EPSP amplitude does not however appear to result from NTPDase inhibition as it persists when both adenosine and ATP (P2Y and P2X) receptors are blocked. An increase in paired pulse ratio and a reduction in presynaptic volley amplitude suggest that there is a presynaptic component of POM-1 action which reduces glutamate release. POM-1 produced similar inhibition at climbing fibre synapses and at hippocampal CA1 pyramidal synapses. Thus although POM-1 is more effective than ARL 67156 at blocking ATP breakdown its usefulness is limited by off-target actions on synaptic transmission.
机译:NTPDase酶的亚型选择性抑制剂和强效抑制剂的发现将大大有助于了解嘌呤能信号传导的机制和性质,该抑制剂可在细胞外空间中代谢核苷酸,例如ATP和ADP。目前,ARL 67156是目前可获得的最好的NTPDase抑制剂,但是其相对较差的功效意味着难以解释阴性结果。 POM-1(聚氧钨酸钠)是一种新型NTPDase抑制剂,在重组NTPDase 1、2和3的抑制作用方面显示出令人鼓舞的结果。我们已经用小脑和海马切片测试了POM-1的有效性和生理作用。使用孔雀石绿色磷酸盐测定法,HPLC和生物传感器测量结果,我们发现POM-1在阻止小脑切片中的ATP分解方面比ARL 67156更有效。抑制位点是分解级联的第一步(ATP转化为ATP ADP)和POM-1的作用似乎很容易逆转。但是,POM-1对突触传递有多种作用。在小脑平行纤维-浦肯野细胞(PF)上,突触POM-1产生了持久的传递抑制作用,在少数突触之前,PF兴奋性突触后电位(EPSP)幅度突然增加(大约20%)。 PF EPSP振幅的这种增加似乎是由于突触前A1受体的强直激活减少所致,与POM-1一致,阻止了ATP分解为腺苷。但是,PF EPSP幅度的降低似乎不是由NTPDase抑制引起的,因为当腺苷和ATP(P2Y和P2X)受体均被阻断时,NTPDase抑制仍然存在。配对脉冲比率的增加和突触前截击幅度的降低表明存在POM-1动作的突触前成分,可减少谷氨酸的释放。 POM-1对攀爬纤维突触和海马CA1锥体突触产生类似的抑制作用。因此,尽管POM-1在阻止ATP分解方面比ARL 67156更有效,但其有效性受到突触传递脱靶作用的限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号